Niall J Lennon, Leah C Kottyan, Christopher Kachulis, Noura S Abul-Husn, Josh Arias, Gillian Belbin, Jennifer E Below, Sonja I Berndt, Wendy K Chung, James J Cimino, Ellen Wright Clayton, John J Connolly, David R Crosslin, Ozan Dikilitas, Digna R Velez Edwards, QiPing Feng, Marissa Fisher, Robert R Freimuth, Tian Ge, Joseph T Glessner, Adam S Gordon, Candace Patterson, Hakon Hakonarson, Maegan Harden, Margaret Harr, Joel N Hirschhorn, Clive Hoggart, Li Hsu, Marguerite R Irvin, Gail P Jarvik, Elizabeth W Karlson, Atlas Khan, Amit Khera, Krzysztof Kiryluk, Iftikhar Kullo, Katie Larkin, Nita Limdi, Jodell E Linder, Ruth J F Loos, Yuan Luo, Edyta Malolepsza, Teri A Manolio, Lisa J Martin, Li McCarthy, Elizabeth M McNally, James B Meigs, Tesfaye B Mersha, Jonathan D Mosley, Anjene Musick, Bahram Namjou, Nihal Pai, Lorenzo L Pesce, Ulrike Peters, Josh F Peterson, Cynthia A Prows, Megan J Puckelwartz, Heidi L Rehm, Dan M Roden, Elisabeth A Rosenthal, Robb Rowley, Konrad Teodor Sawicki, Daniel J Schaid, Roelof A J Smit, Johanna L Smith, Jordan W Smoller, Minta Thomas, Hemant Tiwari, Diana M Toledo, Nataraja Sarma Vaitinadin, David Veenstra, Theresa L Walunas, Zhe Wang, Wei-Qi Wei, Chunhua Weng, Georgia L Wiesner, Xianyong Yin, Eimear E Kenny
Polygenic risk scores (PRSs) have improved in predictive performance, but several challenges remain to be addressed before PRSs can be implemented in the clinic, including reduced predictive performance of PRSs in diverse populations, and the interpretation and communication of genetic results to both providers and patients. To address these challenges, the National Human Genome Research Institute-funded Electronic Medical Records and Genomics (eMERGE) Network has developed a framework and pipeline for return of a PRS-based genome-informed risk assessment to 25,000 diverse adults and children as part of a clinical study...
February 2024: Nature Medicine